Oxford Nanopore Technologies PLC (LSE:ONT) has announced significant breakthroughs in its nanopore sequencing technology at the annual London Calling conference.
Delegates were told its "Q20+" chemistry and Duplex methods achieved record-breaking performance, enabling detailed genome studies with over 99.9% accuracy.
New, smaller format sequencers, including the revamped MinION MkID with iPad Pro connectivity and the high-output PromethION 2, promise accessible sequencing for various environments.
Furthermore, a new kit for direct RNA sequencing will improve RNA research accuracy, which is crucial for studying RNA-based therapies, including vaccines.